These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7011743)
1. An appraisal of the role of biosynthetic human insulin in the future treatment of diabetes mellitus. Gerich JE Diabetes Care; 1981; 4(2):262-4. PubMed ID: 7011743 [TBL] [Abstract][Full Text] [Related]
2. Comparison of biosynthetic human insulin and pork insulin during rest, food ingestion, and physical work in insulin-dependent diabetic subjects using a glucose controlled insulin infusion system. Beyer J; Weber T; Schulz G; Hassinger W; Westerburg A; Cordes U Diabetes Care; 1981; 4(2):189-92. PubMed ID: 7011724 [TBL] [Abstract][Full Text] [Related]
3. Comparison of biosynthetic human insulin and pork insulin in the Gerritzen test. Weinges K; Ehrhardt M; Enzmann F Diabetes Care; 1981; 4(2):180-2. PubMed ID: 7011722 [TBL] [Abstract][Full Text] [Related]
4. Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients. Clark AJ; Adeniyi-Jones RO; Knight G; Leiper JM; Wiles PG; Jones RH; Keen H; MacCuish AC; Ward JD; Watkins PJ; Cauldwell JM; Glynne A; Scotton JB Lancet; 1982 Aug; 2(8294):354-7. PubMed ID: 6124760 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Klier M; Kerner W; Torres AA; Pfeiffer EF Diabetes Care; 1981; 4(2):193-5. PubMed ID: 7011725 [TBL] [Abstract][Full Text] [Related]
6. Biologic and immunologic in vivo and in vitro studies with biosynthetic human insulin. Federlin K; Laube H; Velcovsky HG Diabetes Care; 1981; 4(2):170-4. PubMed ID: 7011720 [TBL] [Abstract][Full Text] [Related]
7. Biologic activity and pharmacokinetics of biosynthetic human insulin in the rat. Halban PA; Berger M; Gjinovci A; Renold AE Diabetes Care; 1981; 4(2):238-43. PubMed ID: 7011735 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial. Karam J; Brink S; Clements R; Miller L; Raskin P Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test]. Richard JL; Rodier M; Cavalie G; Lachkar H; Orsetti A; Monnier L; Mirouze J Diabete Metab; 1986 Feb; 12(1):6-9. PubMed ID: 2870943 [TBL] [Abstract][Full Text] [Related]
10. The plasma glucose response of normal fasting subjects to neutral regular and NPH biosynthetic human and purified pork insulins. Galloway JA; Spradlin CT; Root MA; Fineberg SE Diabetes Care; 1981; 4(2):183-8. PubMed ID: 7011723 [TBL] [Abstract][Full Text] [Related]
11. Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas. Raptis S; Karaiskos C; Enzmann F; Hatzidakis D; Zoupas C; Souvatzoglou A; Diamantopoulos E; Moulopoulos S Diabetes Care; 1981; 4(2):155-62. PubMed ID: 7011717 [TBL] [Abstract][Full Text] [Related]
12. [12 month's therapy with biosynthetic human insulin. Results of a double-blind comparative study with swine and bovine insulin in insulin-dependent diabetics during a multicenter study]. Beyer J; Haas R; Enzmann F; Lauerbach M; Rademacher J; Althoff PH; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Heun K; Kerp L; Lotz N; Mehnert H; Mitzkat HJ; Petersen K; Rosak C; Sailer D; Schlüter K; Schöffling K; Schröder KE; Schumm P MMW Munch Med Wochenschr; 1983 May; Suppl 1():S69-79. PubMed ID: 6408438 [No Abstract] [Full Text] [Related]
13. Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin. Viberti GC; Pickup JC; Keen H; Bilous RW; Mattock M; Jarrett RJ; Glynne A; Rogers R Diabetes Care; 1981; 4(2):175-9. PubMed ID: 7011721 [TBL] [Abstract][Full Text] [Related]
14. [Effect of biosynthetic human insulin and conventional swine insulin in insulin-dependent diabetes mellitus with an artificial endocrine pancreas. Comparative studies]. Schusdziarra M MMW Munch Med Wochenschr; 1983 May; Suppl 1():S35-7. PubMed ID: 6408431 [No Abstract] [Full Text] [Related]
15. Binding of biosynthetic human insulin to human antibodies and receptors. Petersen KG; Schlüter K; Steinhilber S; Kerp L Diabetes Care; 1981; 4(2):248-9. PubMed ID: 7011737 [TBL] [Abstract][Full Text] [Related]
17. Role of human insulin in the treatment of diabetes. Jervell J Acta Endocrinol Suppl (Copenh); 1985; 272():61-4. PubMed ID: 3914806 [No Abstract] [Full Text] [Related]
18. Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin. Bachmann W; Sieger C; Lacher F; Lotz N Diabetes Care; 1981; 4(2):215-9. PubMed ID: 7011730 [TBL] [Abstract][Full Text] [Related]
19. Metabolic and hormonal parameters after insulin-induced hypoglycemia in man, comparison between biosynthetic human insulin and purified pork insulin. Perez Fernandez R; Casanueva FF; Devesa J; Cabezas-Cerrato J Horm Metab Res; 1985 Jul; 17(7):351-4. PubMed ID: 2993143 [TBL] [Abstract][Full Text] [Related]
20. Immunologic properties of biosynthetic human insulin in vitro. Beischer W; Maier V; Jonatha EM; Hartweg D; Kratzsch G Diabetes Care; 1981; 4(2):202-4. PubMed ID: 7011727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]